RETRACTED: Utility of dexmedetomidine on surgical site wound pain undergoing thoracoscopic surgery: A meta‐analysis
International Wound Journal · 2024
DOI: 10.1111/iwj.14629 ↗Kurz gefasst
Metaanalyse in der Zeitschrift International Wound Journal, 2024. Verfasst von Mingzhu Li und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Gaozhou People's Hospital, Gaozhou, Guangdong, China. Hauptthemen laut MEDLINE: Dexmedetomidine, Postoperative Pain, Analgesics, Non-Narcotic, Thoracoscopy. Die Arbeit nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
We conducted this study aimed to evaluate the analgesic effect of dexmedetomidine in thoracoscopic surgery on postoperative wound pain, and to provide a reference for clinical use of the drug. We searched PubMed, Embase, Cochrane Library, Web of Science, Wanfang, Chinese Biomedical Literature Database and China National Knowledge Infrastructure databases, and supplemented with manual searching. We searched from database inception to October 2023, to collect the randomised controlled trials (RCTs) on dexmedetomidine application in thoracoscopic surgery. Two researchers screened all the literature according to the inclusion and exclusion criteria and the literature included in the study was evaluated for quality, extracted information and required data. Stata 17.0 software was employed for data analysis and the outcomes were 2 6, 12, 24 and 48 h postoperative wound visual analog scores (VAS). Twenty‐four RCTs totalling 2246 patients undergoing thoracoscopic surgery were finally included. The analysis revealed dexmedetomidine applied to thoracoscopic surgery significantly reduced the postoperative wound VAS scores at 2 h (SMD: −0.96, 95% CI: −1.57 to −0.36, p = 0.002), 6 h (SMD: −0.98, 95% CI: −1.27 to −0.69, p < 0.001), 12 h (SMD: −1.19, 95% CI: −1.44 to −0.94, p < 0.001), 24 h (SMD: −0.91, 95% CI: −1.16 to −0.66, p < 0.001) and 48 h (SMD: −0.75, 95% CI: −1.02 to −0.48, p < 0.001). Our results suggest dexmedetomidine applied to thoracoscopic surgery can significantly reduce postoperative wound pain, which is worthy of clinical application.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy, Gaozhou People's Hospital, Gaozhou, Guangdong, China.
- Department of Cardiovascular Surgery, Gaozhou People's Hospital, Gaozhou, Guangdong, China.
Zitieren
APA
Li, M., Zhang, K., Lu, H., Liang, Y., Zhang, Y., & Feng, G. (2024). RETRACTED: Utility of dexmedetomidine on surgical site wound pain undergoing thoracoscopic surgery: A meta‐analysis. International Wound Journal. https://doi.org/10.1111/iwj.14629
Vancouver
Li M, Zhang K, Lu H, Liang Y, Zhang Y, Feng G. RETRACTED: Utility of dexmedetomidine on surgical site wound pain undergoing thoracoscopic surgery: A meta‐analysis. International Wound Journal. 2024. doi:10.1111/iwj.14629
BibTeX
@article{Li2024,
author = {Li, Mingzhu and Zhang, Kaitian and Lu, Huanqian and Liang, Yuqiong and Zhang, Yuling and Feng, Guifeng},
title = {RETRACTED: Utility of dexmedetomidine on surgical site wound pain undergoing thoracoscopic surgery: A meta‐analysis},
journal = {International Wound Journal},
year = {2024},
doi = {10.1111/iwj.14629}
}
EUVIMED